From Forbes via the Associated Press: "Journal Article a Wild Card in Vioxx Trial," by Janet McConnaughey--
A top medical journal's criticism of a study cited in Vioxx lawsuits is expected to play a part in the retrial of the first federal Vioxx lawsuit - but it's not clear if it will be a legal hand grenade or a nuclear warhead.
The disclosure that some negative data was omitted from the study could make manufacturer Merck & Co. look as if it's hiding something, legal experts say. That is what attorneys for Evelyn Irvin Plunkett, whose husband died after taking the drug for a month, say they can prove in the trial starting Monday.
--Posted by Illinois Vioxx attorney T. Evan Schaeffer of the East Alton Illinois Vioxx law firm of Schaeffer & Lamere, P.C.
Comments